ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020
Ipilimumab and Nivolumab in Rare Tumors S1609: Neuroendocrine-Response.
Sandip P Patel et al.PubMed ↗Publisher ↗
No numbers read from the abstract.